Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Boston Strategics Corporation Initiates A Phase 1 Clinical Trial Of The Anti-Cancer Agent FF-10501' For FUJIFILM In Patients With Advanced Hematologic Malignancies

 

Boston Strategics Corporation Initiates A Phase 1 Clinical Trial Of The Anti-Cancer Agent FF-10501' For FUJIFILM In Patients With Advanced Hematologic Malignancies

2014-09-03 11:37:54| drugdiscoveryonline Home Page

Boston Strategics Corporation (BSC), a primary global strategic drug development provider for FUJIFILM Pharmaceuticals U.S.A., Inc. (FPHU), has begun a Phase 1 clinical trial of FUJIFILM’s anti-cancer agent FF-10501 in the United States in patients with advanced hematologic malignancies, such as relapsed or refractory high-risk myelodysplastic syndromes (MDS)

Tags: with advanced corporation agent

Category:Biotechnology and Pharmaceuticals

Latest from this category	All news
»	01.07 Union expected to call off Port Talbot strike action 01.07 Mentorship in Motion 01.07 Farm Progress America, July 1, 2024 01.07 Hurricane Beryl Forecast Discussion Number 11 01.07 Hurricane Beryl Graphics 01.07 Hurricane Beryl Wind Speed Probabilities Number 11 01.07 Hurricane Beryl Forecast Advisory Number 11 01.07 Hurricane Beryl Public Advisory Number 11 More »